AndrewSBombackMD

Assistant Professor, Medicine, Columbia University College of Phys & Surg

Overview of Dr. Bomback

Dr. Andrew Bomback is a nephrologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 14 years. Dr. Bomback accepts several types of health insurance, listed below. He is one of 171 doctors at New York-Presbyterian Hospital and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Nephrology. He has more than 100 publications and over 500 citings.

Office
622 W 168th St
Ph 4-124
New York, NY 10032
Book by Phone+1(929) 334-3633

Education & Training

University of North Carolina HospitalsResidency, Internal Medicine, 2004 - 2008
Columbia University Vagelos College of Physicians and SurgeonsClass of 2003

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2009 - 2026
NJ State Medical License 2022 - 2025
CT State Medical License 2022 - 2023
NC State Medical License 2004 - 2009
American Board of Internal Medicine Nephrology

Clinical Trials

Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Start of enrollment: 2009 Feb 01
Completed
Phase 4
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
Completed
Phase 2
MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
Completed
Phase 2, Phase 3
Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
Recruiting
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients Start of enrollment: 2011 Oct 01
Completed
Join now to see all

Publications & Presentations

PubMed

47 citations
Kidney Transplantation in C3 Glomerulopathy: A Case Series.
Renu Regunathan-Shenk, Rupali S. Avasare, Wooin Ahn, Pietro A. Canetta, David J. Cohen
American Journal of Kidney Diseases. 2019-03-01
251 citations
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
Andrew S. Bomback, Richard J.H. Smith, Gaetano R. Barile, Yuzhou Zhang, Eliot Heher
Clinical Journal of the American Society of Nephrology. 2012-05-01
45 citations
Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series
Rupali S. Avasare, Pietro A. Canetta, Andrew S. Bomback, Maddalena Marasa, Yasar Caliskan
Clinical Journal of the American Society of Nephrology. 2018-03-07

Other

Diagnosis and classification of renal disease in systemic lupus erythematosus
Bomback AS, Appel GB
http://www.uptodate.com/contents/diagnosis-and-classification-of-renal-disease-in-systemic-lupus-ery
UpToDate, Wolters Kluwer Health - 2013-02-28
End-stage renal disease due to lupus nephritis
Bomback AS, Appel GB
http://www.uptodate.com/contents/end-stage-renal-disease-due-to-lupus-nephritis
UpToDate, Wolters Kluwer Health - 2013-04-12

Press Mentions

Novartis Oral Fabhalta® (Iptacopan) Sustained Clinically Meaningful Results at One Year in Phase III C3 Glomerulopathy (C3G) TrialOctober 26th, 2024
The Sentence That Broke MeApril 29th, 2020
The Stethoscope Has Much to Teach, if We Just ListenAugust 16th, 2017
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Florida BlueSelect
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Wyoming BlueChoice Personal
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment